5-hydroxyflavone has been researched along with 4',7-dihydroxyflavone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Albasini, A; Antolini, L; Bose, P; Costantino, L; Del Corso, A; Gamberini, MC; Iannone, A; Mura, U; Rastelli, G; Staffieri, M; Vinson, JA | 1 |
Arioka, S; Hinou, H; Nishimura, S; Sakagami, M; Takemoto, H; Togame, H; Uematsu, R; Yamaguchi, H | 1 |
Fernandes, E; Freitas, M; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM | 1 |
Cabrita, EJ; Fernandes, E; Freitas, M; Marques, MM; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM | 1 |
Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
5 other study(ies) available for 5-hydroxyflavone and 4',7-dihydroxyflavone
Article | Year |
---|---|
1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
Topics: Aldehyde Reductase; Animals; Antioxidants; Benzopyrans; Cattle; Enzyme Inhibitors; Humans; Kidney; Lens, Crystalline; Lipoproteins, LDL; Lipoproteins, VLDL; Models, Molecular; Oxidation-Reduction; Structure-Activity Relationship | 1999 |
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
Topics: Base Sequence; DNA Primers; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycoproteins; Neuraminidase; Recombinant Proteins; Structure-Activity Relationship; Trypanosoma cruzi | 2010 |
Modulation of human neutrophils' oxidative burst by flavonoids.
Topics: Flavonoids; Humans; Luminescent Measurements; Molecular Structure; Neutrophils; Oxidation-Reduction | 2013 |
Inhibition of LOX by flavonoids: a structure-activity relationship study.
Topics: Dose-Response Relationship, Drug; Flavonoids; Glycine max; Humans; Leukotriene B4; Lipoxygenase; Molecular Structure; Neutrophils; Structure-Activity Relationship | 2014 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |